Because of the presence of FOXC2 in skeletal precursor cells [22] and involvement in osteogenic differentiation [23–26], we hypothesized that FOXC2 may play a role in a tumor type with altered osteogenic differentiation, such as osteosarcoma. This evidence concerns the gene FOXC2 and neoplasm.